MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-14-0002210
Decro Pharma Private Limited - chemicals and materials in Indrad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.66 Cr
▲ 96% YoY
Net loss · FY 2025
₹3.6 Cr
Net margin -24.6%
EBITDA · FY 2025
-₹2.52 Lakh
EBITDA margin -0.2%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.5 Cr
Issued & subscribed
Open charges
₹38.8 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
6
As per MCA filings
About Decro Pharma Private Limited
Data last updated:
Decro Pharma Private Limited is a private limited company based in Indrad, Gujarat, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 21 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24210GJ2020PTC117562. Its GSTIN is 24AAICD0828L1ZM (Gujarat).
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.5 Cr. It is led by directors including Narendra Rajdev Pandey and Bhikan Nimba Patil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at New Survey No. – 466 Plot No 7 Umiya Industrial Estate Ta. Kadi, Indrad, Gujarat, India – 382715.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.66 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net loss of ₹3.6 Cr (net margin -24.6%) and EBITDA of -₹2.52 Lakh (EBITDA margin -0.2%).
As per MCA filings, the company has open charges of ₹38.8 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in May 2022. Its 6 peer companies in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Pondy Agro Chemicals Pvt.Ltd. with revenue of ₹14.74 Cr.
Decro Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0002210). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website decropharma.com.
Company details
CIN U24210GJ2020PTC117562
Registration Number 117562
Incorporation Date 21 October 2020
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-14-0002210
Key People
Narendra Rajdev Pandey Director Bhikan Nimba Patil Director Hareshbhai Kalabhai Patel Director Recognitions & Rankings of Decro Pharma
Contact details
Decro Pharma Private Limited's registered office is in Indrad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNew Survey No. – 466 Plot No 7 Umiya Industrial Estate Ta. Kadi, Indrad, Gujarat, India – 382715
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Decro Pharma Private Limited, buy the company report.
Comprehensive company report
Decro Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Decro Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Decro Pharma Private Limited, buy the company report.
Financials of Decro Pharma Private Limited
FY 2025 filings availableDecro Pharma Private Limited reported revenue of ₹14.66 Cr (up 96% YoY) for FY 2025.
Revenue · FY 2025
₹14.66 Cr ▲ 96%
Net loss · FY 2025
₹3.6 Cr margin -24.6%
EBITDA · FY 2025
-₹2.52 Lakh margin -0.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 96%
EBITDA CAGR growth
1 year
▼ 102%
3 years · compounded
▼ 375%
Revenue rose 96% in the latest year. EBITDA fell 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.6 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -24.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Decro Pharma Private Limited, buy the company report.
Board of directors of Decro Pharma Private Limited
Decro Pharma has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Rajdev Pandey | Director | 21 Oct 2020 | 6 Years 0 Months | Current |
| Bhikan Nimba Patil | Director | 21 Oct 2020 | 6 Years 0 Months | Current |
| Hareshbhai Kalabhai Patel Also directs: Vachanamrut Foundation | Director | 21 Oct 2020 | 6 Years 0 Months | Current |
| Rakesh Ambalal Patel Also directs: Decro Colors Private Limited, Umiya Enviro Project LLP | Director | 21 Oct 2020 | 6 Years 0 Months | Current |
| Sangitaben Rakeshkumar Patel Also directs: Decro Colors Private Limited | Director | 08 May 2021 | 5 Years 5 Months | Current |
| Arvindbhai Patel | Director | 08 May 2021 | 5 Years 5 Months | Current |
Peer comparison
Decro Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pondy Agro Chemicals Pvt.Ltd. | ₹14.74 Cr (FY 2025) | 4.0% | Puducherry, India | |||
| Swarup Chemicals Private Limited | ₹14.73 Cr (FY 2025) | 16.0% | Uttar Pradesh, India | |||
| Shyamal Life Science Private Limited | ₹14.69 Cr (FY 2025) | 45.0% | Vapi, Gujarat, India | |||
| Crescent R&D Private Limited | ₹14.67 Cr (FY 2024) | -57.0% | Sriperumbudur, Tamil Nadu, India | |||
| Decro Pharma Private Limitedthis company | ₹14.66 Cr (FY 2025) | -₹3.6 Cr | -24.6% | 96.0% | Indrad, Gujarat, India | |
| Shalimar Seal and Tar Products Private Limited | ₹14.62 Cr (FY 2025) | 5.0% | Jaipur, Rajasthan, India | |||
| Life Medicare and Biotech Private Limited | ₹14.62 Cr (FY 2025) | 328658.0% | New Delhi, Delhi, India |
To see the full peer comparison of Decro Pharma Private Limited, buy the company report.
Auditor
Decro Pharma Private Limited is audited by G.C.PATEL & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.C.PATEL & CO. | FY 2023 | 113693W |
Shareholding
The shareholding of Decro Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Decro Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹38.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2022 | 100567876 | State Bank of India | ₹19.4 Cr | Open | |
| 30 Mar 2022 | 100568091 | State Bank of India | ₹19.4 Cr | Open |
To see the full charge records of Decro Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Decro Pharma Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in May 2022.
Total deals
2
Rights issue
1
Secondary share transfer
1
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2022 | Rights issue | ₹5.49 Cr | Investors: 4 individuals |
| May 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Decro Pharma Private Limited has 1 court case on record: 1 filed by Decro Pharma. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mahesana, Gujarat | Criminal complaint | Filed by the company against individuals | Pending |
To see the full case history of Decro Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Decro Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Decro Pharma Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
Decro Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICD0828L1ZM | Gujarat | Active | 30 Dec 2020 |
To see the full GST registrations and return filing status of Decro Pharma Private Limited, buy the company report.
Recent activity
Decro Pharma Private Limited has 6 board changes on record since 2020: 6 appointments. The latest: Arvindbhai Patel was appointed as Director on 08 May 2021.
AGM
Decro Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Decro Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with State Bank Of India of Rs. 19.40 Cr registered on 30 Mar 2022 with Charge ID 100567876 was modified on 26 Apr 2024.
Charges
A charge with State Bank Of India of Rs. 19.40 Cr registered on 30 Mar 2022 with Charge ID 100568091 was modified on 26 Apr 2024.
Charges
A charge with State Bank Of India amounted to Rs. 19.40 Cr with Charge ID 100567876 was registered on 30 Mar 2022.
Charges
A charge with State Bank Of India amounted to Rs. 19.40 Cr with Charge ID 100568091 was registered on 30 Mar 2022.
Appointed
Arvindbhai Patel was appointed as Director.
Appointed
Sangitaben Rakeshkumar Patel was appointed as Director.
Appointed
Bhikan Nimba Patil was appointed as Director.
Appointed
Hareshbhai Kalabhai Patel was appointed as Director.
Appointed
Narendra Rajdev Pandey was appointed as Director.
Appointed
Rakesh Ambalal Patel was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Decro Pharma is an active private limited company based in Indrad, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 21 October 2020 (6+ years old) and is registered under CIN U24210GJ2020PTC117562.
Decro Pharma has 6 current directors:
- Narendra Rajdev Pandey - Director
- Bhikan Nimba Patil - Director
- Hareshbhai Kalabhai Patel - Director
- Rakesh Ambalal Patel - Director
- Sangitaben Rakeshkumar Patel - Director
- Arvindbhai Patel - Director
The latest financial statements of Decro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Decro Pharma is 24AAICD0828L1ZM, registered in Gujarat.
The CIN (Corporate Identification Number) of Decro Pharma is U24210GJ2020PTC117562. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Decro Pharma has 1 court case on record: 1 filed by the company. 1 is pending.
Decro Pharma was incorporated on 21 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Decro Pharma has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in May 2022.
The peers of Decro Pharma by revenue are Pondy Agro Chemicals Pvt.Ltd, Swarup Chemicals Private Limited, Shyamal Life Science Private Limited, Crescent R&D Private Limited, Shalimar Seal and Tar Products Private Limited and 1 more, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arvindbhai Patel was appointed as Director on 08 May 2021. Sangitaben Rakeshkumar Patel was appointed as Director on 08 May 2021. Bhikan Nimba Patil was appointed as Director on 21 Oct 2020. Decro Pharma has 6 board changes on record in total.
Yes, Decro Pharma is registered as an MSME under Udyam registration (number: UDYAM-GJ-14-0002210).